An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Every step of the way, Rose Booker, formally of the Durham Catholic District School Board, has worked tirelessly to make sure ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

Amgen (AMGN) stock spiked after the company ruled out out bone density concerns linked to obesity drug MariTide, following a ...

Amgen (AMGN) issued the following statement on the MariTide Phase 1 data. “As previously stated, Amgen does not see an association ...

Devarakonda covers the Healthcare sector, focusing on stocks such as Amgen, Eli Lilly & Co, and Incyte. In addition to Truist Financial, Amgen also received a Hold from Barclays’s Carter Gould in a ...

PLYMOUTH MEETING, Pa., Nov. 13, 2024 /PRNewswire/ -- ECRI, a global healthcare safety nonprofit organization, named St. Joseph's Health the winner of the 2024 Safety Excellence Award, in recognition ...

CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the ...